Pharmaceutical Drugs

What is Zofran?

Zofran, originally developed by GlaxoSmithKline and was marketed by them in 1991, was approved by the FDA to treat nausea in cancer patients undergoing chemotherapy and radiation treatment and for postoperative surgery patients.  It has become one of the most prescribed drugs for nausea in the United States.  Zofran is also known as Zuplenz.

Zofran Risk

From: HarrisMartin's Drugs & Medical Devices Publication

Date: July 17, 2014

www.harrismartin.com

W. Va. Federal Judge Strikes Forest Labs' Learned Intermediary

Defense in Lexapro Suicide Case

WHEELING, W. Va. - A West Virginia federal judge has granted a plaintiff's motion to strike a drug maker's learned intermediary defense in a Lexapro suicide case, noting the state's high court has expressly declined to adopt the learned intermediary doctrine.

Pendley, Baudin and Coffin, L.L.P. has been the first law firm to file a Lipitor suit in Louisiana; the firm has also filed a suit in South Carolina.

Lipitor, a cholesterol lowering statin medication, and its generic version atorvastatin have been linked to an increased risk for diabetes in women. Studies found that women aged of 50 to 79, who were taking Lipitor or the generic atorvastatin, were at a higher risk of developing Type 2 diabetes. Lipitor is produced and sold by Pfizer a pharmaceutical company.

Class Action Litigation Report

May 15, 2014

Pharmaceuticals

Hundreds of Women Sue Pfizer; Failure to Warn of Diabetes Risk Alleged

By Julie A. Steinberg

The FDA is investigating the risk of heart attack, stroke and death in men using FDA approved prescription testosterone products. A study by the National Cancer Institute and a study published in the Journal of The American Medical Association (JAMA), in November of 2013, prompted the FDA investigation. The studies showed that three months after beginning "low-T" treatments with testosterone therapy drugs, the risk of heart attack doubled among men over 65 and younger men with a history of heart disease.

Testosterone Replacement Therapy Side Effects:

Pendley, Baudin and Coffin, L.L.P. has been the first law firm to file a Lipitor suit in Louisiana; the firm has also filed a suit in South Carolina.

Lipitor, a cholesterol lowering statin medication, and its generic version atorvastatin have been linked to an increased risk for diabetes in women. Studies found that women aged of 50 to 79, who were taking Lipitor or the generic atorvastatin, were at a higher risk of developing Type 2 diabetes. Lipitor is produced and sold by Pfizer a pharmaceutical company.